ConductScience.org, home

Paper17469029

Impact of the degree of hydronephrosis on the efficacy of in situ extracorporeal shock-wave lithotripsy for proximal ureteral calculi.

El-Assmy A and 4 others. Scand J Urol Nephrol, 2007. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Impact of the degree of hydronephrosis on the efficacy of in situ extracorporeal shock-wave lithotripsy for proximal ureteral calculi. Papers, record 17469029. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17469029

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of the degree of hydronephrosis on the efficacy of in situ extracorporeal shock-wave lithotripsy for proximal ureteral calculi.
PubMed
Journal
Scand J Urol Nephrol
PubMed
Year
2007
PubMed
Publication types
Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
0.74
iCite
Revised in PubMed
2016-11-24
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1El-Assmy AAhmed
2El-Nahas ARAhmed R
3Youssef RFRamy F
4El-Hefnawy ASAhmed S
5Sheir KZKhaled Z

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HydronephrosisMajor topic
LithotripsyMajor topic
Ureteral CalculiMajor topic
Adolescent
Adult
Aged
Female
Humans
Kidney
Male
Middle Aged
Prospective Studies
Time Factors
Treatment Outcome
Ultrasonography
Ureter

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
39821148Impact of hydronephrosis on shockwave lithotripsy outcomes for upper ureteral stones.Int Urol Nephrol2025https://conductscience.org/library/papers/39821148PubMed
36585472
Development and validation of a predictive model for treatment outcome after emergency extracorporeal shockwave lithotripsy in patients with symptomatic ureteral stones during the COVID-19 pandemic: in a large prospective cohort.
Urolithiasis2022https://conductscience.org/library/papers/36585472PubMed
35223107The effect of stone size on the results of extracorporeal shockwave lithotripsy versus semi-rigid ureteroscopic lithotripsy in the management of upper ureteric stones.Arab J Urol2022https://conductscience.org/library/papers/35223107PubMed
33210203Laser lithotripsy for proximal ureteral calculi in adults: can 3D CT texture analysis help predict treatment success?Eur Radiol2021https://conductscience.org/library/papers/33210203PubMed
32279108Factors affecting success in the treatment of proximal ureteral stones larger than 1 cm with extracorporeal shockwave lithotripsy in adult patients.Urolithiasis2021https://conductscience.org/library/papers/32279108PubMed
31606779Does the presence or degree of hydronephrosis affect the stone disintegration efficacy of extracorporeal shock wave lithotripsy? A systematic review and meta-analysis.Urolithiasis2020https://conductscience.org/library/papers/31606779PubMed
28792145Impact of Pretreatment Hydronephrosis on the Success Rate of Shock Wave Lithotripsy in Patients with Ureteral Stone.Yonsei Med J2017https://conductscience.org/library/papers/28792145PubMed
28348743Management of upper ureteral stones exceeding 15 mm in diameter: Shock wave lithotripsy versus semirigid ureteroscopy with holmium:yttrium-aluminum-garnet laser lithotripsy.SAGE Open Med2016https://conductscience.org/library/papers/28348743PubMed
23413950Recent finding and new technologies in nephrolitiasis: a review of the recent literature.BMC Urol2013https://conductscience.org/library/papers/23413950PubMed
19343443Extracorporeal shock wave lithotripsy as a first-line therapy for ureteral calculi with impaired renal function due to hydronephrosis.Surg Endosc2009https://conductscience.org/library/papers/19343443PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17469029

GET https://conductscience.org/api/papers/v1/17469029/authors